Uzbekistan vs Zimbabwe: Dealing with construction permits: Quality control after construction
Uzbekistan
3 DB16-20 methodology
in 2019
Zimbabwe
3 DB16-20 methodology
in 2019
Uzbekistan rank
1st
Zimbabwe rank
1st
Dealing with construction permits: Quality control after construction over time
- Uzbekistan
- Zimbabwe
How they compare
Uzbekistan currently reports 3 DB16-20 methodology against 3 DB16-20 methodology in Zimbabwe, a difference of 0 DB16-20 methodology.
Across all 6 years both countries report, Zimbabwe has been ahead every year.
Uzbekistan ranks 1st and Zimbabwe ranks 1st of 186 countries.
Frequently asked questions
- Which has higher dealing with construction permits: quality control after construction, Uzbekistan or Zimbabwe?
- Uzbekistan, at 3 DB16-20 methodology against 3 DB16-20 methodology in Zimbabwe as of 2019.
- What is the difference in dealing with construction permits: quality control after construction between Uzbekistan and Zimbabwe?
- 0 DB16-20 methodology, with Uzbekistan ahead.
- How many years of comparable data are there for Uzbekistan and Zimbabwe?
- 6 years are reported by both, from 2014 to 2019.
- How do Uzbekistan and Zimbabwe rank globally for dealing with construction permits: quality control after construction?
- Uzbekistan ranks 1st and Zimbabwe ranks 1st of 186 countries.
- Where does this data come from?
- The World Bank, published as Dealing with construction permits: Quality control after construction index (0-3) (DB16-20 methodology). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The quality control after construction index evaluates quality control after the construction process. It has two components: (i) whether a final inspection is mandated by law to verify that the building was built in accordance with the approved plans and existing building regulations; and (ii) whether the final inspection is implemented in practice. The index is computed based on the methodology in the DB16-20 studies.